anmelden
SPI
20.270,57
PKT
+7,35
PKT
+0,04
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu SPI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 11.07.12 | Kühne + Nagel International buy | Nomura | |
| 11.07.12 | OC Oerlikon hold | Société Générale Group S.A. (SG) | |
| 11.07.12 | Helvetia Baloise hold | Vontobel Research | |
| 11.07.12 | Swiss Life buy | Vontobel Research | |
| 10.07.12 | Logitech neutral | Sarasin Research | |
| 10.07.12 | Sonova neutral | Sarasin Research | |
| 10.07.12 | Galenica neutral | Sarasin Research | |
| 10.07.12 | Logitech hold | Vontobel Research | |
| 09.07.12 | Nestlé reduce | Nomura | |
| 09.07.12 | Holcim hold | Vontobel Research | |
| 09.07.12 | Clariant buy | Vontobel Research | |
| 09.07.12 | Galenica hold | Vontobel Research | |
| 06.07.12 | UBS overweight | HSBC | |
| 06.07.12 | Swiss Re neutral | HSBC | |
| 06.07.12 | UBS overweight | HSBC | |
| 06.07.12 | Barry Callebaut neutral | UBS AG | |
| 06.07.12 | Temenos neutral | UBS AG | |
| 06.07.12 | Barry Callebaut buy | Société Générale Group S.A. (SG) | |
| 06.07.12 | GAM neutral | Sarasin Research | |
| 06.07.12 | SGS SA buy | Vontobel Research | |
| 05.07.12 | Novartis buy | Deutsche Bank AG | |
| 05.07.12 | Barry Callebaut neutral | Sarasin Research | |
| 05.07.12 | Swiss Re hold | Société Générale Group S.A. (SG) | |
| 05.07.12 | Barry Callebaut hold | Vontobel Research | |
| 05.07.12 | SGS SA buy | Vontobel Research | |
| 05.07.12 | Kühne + Nagel International hold | Vontobel Research | |
| 04.07.12 | Swiss Re neutral | Exane-BNP Paribas SA | |
| 04.07.12 | Holcim sell | Goldman Sachs Group Inc. | |
| 04.07.12 | Holcim neutral | Goldman Sachs Group Inc. | |
| 04.07.12 | Clariant hold | Deutsche Bank AG | |
| 04.07.12 | Givaudan sell | Deutsche Bank AG | |
| 04.07.12 | Kühne + Nagel International overweight | J.P. Morgan Cazenove | |
| 04.07.12 | Emmi hold | Vontobel Research | |
| 03.07.12 | Holcim outperform | Exane-BNP Paribas SA | |
| 03.07.12 | Arbonia neutral | UBS AG | |
| 03.07.12 | Schweiter buy | UBS AG | |
| 03.07.12 | Temenos outperform | Exane-BNP Paribas SA | |
| 03.07.12 | Zurich Insurance buy | Nomura | |
| 03.07.12 | Swiss Re buy | Sarasin Research | |
| 03.07.12 | Nestlé kaufen | Norddeutsche Landesbank (Nord/LB) |
